Managing benign prostatic hyperplasia

Practitioner. 2001 Oct;245(1627):830-2, 834, 836 passim.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use
  • Enzyme Inhibitors / therapeutic use
  • Finasteride / therapeutic use
  • Humans
  • Male
  • Mass Screening / methods
  • Prostate-Specific Antigen / blood
  • Prostatectomy / methods
  • Prostatic Hyperplasia / diagnosis
  • Prostatic Hyperplasia / etiology
  • Prostatic Hyperplasia / therapy*

Substances

  • Adrenergic alpha-Antagonists
  • Enzyme Inhibitors
  • Finasteride
  • Prostate-Specific Antigen